NASDAQ:IMNN
Imunon, Inc.
Imunon, Inc. reported net income of −$14.5M in fiscal 2025. Free cash flow was −$14.2M, and the diluted share count rose 93.2%.Summary generated from Imunon, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−256.4%
Debt / equityn/a
Free cash flow−$14.2M
FCF marginn/a
Share count change+93.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 1 | n/a | n/a | n/a |
| Operating income | −21 | −25 | −21 | −19 | −15 |
| Net income | −21 | −36 | −20 | −19 | −14 |
| Free cash flow | −17 | −23 | −19 | −19 | −14 |
Recent filings
- 8-KEntry into a material agreement
Sep 29, 2026 - 4Insider transaction report
Sep 28, 2026 - 4Insider transaction report
Sep 28, 2026 - 8-KDirector or officer change
Aug 11, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 8-KDirector or officer change
Jun 30, 2026 - 8-KDirector or officer change
Jun 16, 2026